Research on Herbal Remedies and Pharmaceuticals in Alzheimer’s Treatment
Introduction to Alzheimer’s Disease
Alzheimer’s disease is a neurodegenerative disorder marked by the buildup of toxic proteins in the brain, resulting in cognitive decline, memory loss, and dementia. As of 2017, it is estimated that nearly 50 million individuals globally are living with this condition. The progression of Alzheimer’s is complex and not completely understood, complicating the identification and treatment of its underlying causes.
Current Therapeutic Approaches
Several medications have been developed to temporarily alleviate the symptoms of Alzheimer’s. These conventional therapies primarily fall into two categories: cholinesterase inhibitors and NMDA receptor agonists. Most of these drugs target a single mechanism, and they are often used in combination to enhance the therapeutic effects. However, their efficacy typically diminishes significantly after the initial three to six months of treatment.
Exploring Herbal Medicine
Herbal medicine presents an alternative approach to treating various health issues, with practices rooted in East Asian cultures, particularly in China, for thousands of years. While empirical evidence exists to support the effectiveness of herbal remedies, they have faced criticism in scientific communities for lacking clearly defined mechanisms of action.
Commonly, herbal treatments involve a blend of herbs and extracts brewed in hot water. One example is the GRAPE formula, which incorporates up to ten different herbs aimed at boosting energy, reducing inflammation, and enhancing circulation. The combination of herbal medicine with conventional therapies represents a promising area of research, particularly in improving treatment outcomes for diseases like Alzheimer’s.
Recent Study on Hybrid Therapy
A recent study in China, conducted by neurologists and herbal medicine specialists, aimed to evaluate the potential benefits of merging conventional and herbal therapies for Alzheimer’s symptoms. The findings were published in BMC Complementary and Alternative Medicine. This retrospective cohort study included 344 Alzheimer’s patients, who were divided into two groups: one receiving conventional therapy (CT) and the other receiving a combination of conventional therapy and herbal treatment (CT+H).
The researchers analyzed detailed medical records and assessed the disease levels at the study’s onset using neuroimaging and the mini-mental state examination (MMSE), which evaluates cognitive function. These scores were adjusted based on factors such as education and literacy. Over two years, the MMSE data were collected quarterly from both groups and compared.
Findings of the Study
The results indicated that patients in the herbal group consistently achieved higher MMSE scores throughout the 24-month study period compared to those receiving only conventional therapy. While patients on conventional therapy fell below baseline MMSE scores after six months, those in the herbal group maintained their scores for an additional six months, only declining after 12 months. Furthermore, the disparity in MMSE scores between the two groups widened during the second year, suggesting that the herbal group experienced a stabilizing effect on their symptoms from 18 to 24 months.
These findings imply that combining herbal therapies with conventional medications may offer more prolonged benefits than conventional therapies alone.
Limitations and Future Research
The authors of the study acknowledged certain limitations that future research could address. The retrospective nature of the study raises concerns about selection bias, leading them to recommend a full prospective, randomized, double-blind trial to validate these results.
Conclusion
This study raises intriguing questions about the integration of herbal medicine with modern pharmaceuticals and its potential to enhance treatment for Alzheimer’s disease.
Written by Adriano Vissa, Ph.D.
References
(1) Shi J et al. (2017). Adding Chinese herbal medicine to conventional therapy brings cognitive benefits to patients with Alzheimer’s disease: a retrospective analysis. BMC Complementary and Alternative Medicine. 17:533 DOI 10.1186/s12906-017-2040-5
(2) Prince, M., et al. “World Alzheimer Report 2015. The global impact of dementia. An analysis of prevalence, incidence, cost & trends; Alzheimer’s Disease International: London.” (Accessed February 17, 2016)(2015).